Jan. 4, 2012
/PRNewswire/ -- The Female Health Company (NASDAQ-CM: FHCO - News), which manufactures and markets the
FC2 Female Condom®
, today announced that it will be presenting at the
Sidoti & Company 2012 Semi-Annual New York Micro-Cap Conference
, 2012. The Conference will be held at The Grand Hyatt in
New York City
, Chief Executive Officer, and
, Chief Financial Officer, will present an overview of The Female Health Company at
2:00 PM Eastern Time
Monday, January 9, 2012
in the Estate 2 Edison room. The Company's executives will also meet with investors to discuss the Company's ongoing operations.
About Sidoti & Company, LLC
Sidoti & Company, LLC
, founded in 1999, continues to set the Wall Street standard for independent small-cap equity research, while rapidly becoming a driving force in micro-cap research, launching coverage of more than 100 equities of
market cap or less since inception in mid-2010. Its analysts mine dozens of industries to provide unbiased, institutional-quality research focusing on the investment merits of profitable companies at a sub-
market cap, and it anticipates extending coverage to 700 small-cap equities by the end of 2012.
About The Female Health Company
The Female Health Company, based in
, manufactures and markets the
FC2 Female Condom® (FC2),
which is available in the U.S. and in about 120 other countries globally. The Company owns certain worldwide rights to the
FC2 Female Condom
®, including patents that have been issued in the U.S., the European
The People's Republic of China
and the African Regional Intellectual Property Organization (ARIPO), which includes
, United Republic of
and Zimbabwe. FC2 patent applications are pending in various countries.
The FC2 Female Condom®
is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: